Imaging markers for Alzheimer disease
Giovanni B. Frisoni(University of Geneva), Clifford R. Jack(Mayo Clinic), Gaël Chételat(Inserm), Nick C. Fox(NIHR Queen Square Dementia Biomedical Research Unit), Patrizio Pasqualetti(Sapienza University of Rome), Christopher C. Rowe(The University of Melbourne), Philip Scheltens(Inserm), María C. Carrillo(Alzheimer's Association), William Thies(Stroke Association), Lars‐Olof Wahlund(Karolinska Institutet), Charles DeCarli(University of California, Davis), Jeffrey Kaye(Oregon Health & Science University), Sandra E. Black(Sunnybrook Health Science Centre), David J. Brooks(Hammersmith Hospital), Eric M. Reiman(Alzheimer's Association), Gil D. Rabinovici(University of California, San Francisco), Karl Herholz(University of Manchester), William J. Jagust(Lawrence Berkeley National Laboratory), Frederik Barkhof(Netherlands Institute for Neuroscience), Martina Bocchetta(UK Dementia Research Institute), Mony J. de Leon(Nathan Kline Institute for Psychiatric Research), Agneta Nordberg(Uppsala University), Keith A. Johnson(Jacobson Holman (United States)), Reisa A. Sperling(Harvard University), Michael W. Weiner(University of California, San Francisco)
Cited by 223
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Consistent resting-state networks across healthy subjects
|Proceedings of the National Academy of Sciences|2006|4.4k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k